Acquired von Willebrand Syndrome

Link to article at PubMed

Hematol Oncol Clin North Am. 2021 Aug 11:S0889-8588(21)00084-8. doi: 10.1016/j.hoc.2021.07.005. Online ahead of print.


Acquired von Willebrand syndrome can occur in the setting of myeloproliferative neoplasms; plasma cell dyscrasias and other lymphoproliferative disorders; autoimmune conditions; and causes of increased shear forces, such as aortic stenosis or other structural heart disease and mechanical circulatory support. The depletion of von Willebrand factor, especially high-molecular-weight multimers, can lead to mucocutaneous bleeding and the formation of arteriovenous malformations, particularly in the gastrointestinal tract. Management focuses on correction of the underlying cause when possible, but may include intravenous immunoglobulins, von Willebrand factor concentrate, rituximab, or antiangiogenic therapy depending on the clinical context.

PMID:34391604 | DOI:10.1016/j.hoc.2021.07.005

Leave a Reply

Your email address will not be published.